We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Anaerobic Chamber Ideal for Low Oxygen Conditions

By LabMedica International staff writers
Posted on 24 May 2012
An anaerobic chamber is ideal for low oxygen conditions in microaerophilic bacteriology, tissue, and cell culture applications.

The Shel Lab Bactrox chamber was introduced by Sheldon Manufacturing, Inc. More...
(Cornelius, OR, USA) and is the latest addition to its Bactron line of anaerobic chambers. The Bactrox offers precise oxygen and carbon dioxide control from 1%-20%.

The Bactrox is suitable for clinical and research microbiology, stem cell research, and mammalian cancer research. The chamber preserves optimal application conditions not only during incubation but also in the chamber workstation. Removal of cultures from the incubator does not require exposure of cells to undesirable oxygen or carbon dioxide levels.

The atmosphere in the unit is controlled by an accurate and long-lasting zirconium dioxide oxygen sensor, with independent oxygen and carbon dioxide control and logging. This minimizes setting up time. The Bactrox also has a standalone 300 plate incubator so users can comfortably work without gloves in ambient room conditions.

There is a large vacuum-less sample pass box that takes only 60 seconds to purge. The new design provides a vacuum-less sleeve entry into the chamber. Other features of this unit include temperature control and logging, superior condensation control, and ultra-bright light-emitting diode (LED) examination lights inside the chamber.

Related Links:

Sheldon Manufacturing




New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
New
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The method that profiles DNA methylation in cell-free DNA from a single blood sample to detect disease signals system-wide (photo courtesy of Shutterstock)

cfDNA Methylation Assay Enables Multi-Disease Detection from Single Blood Sample

Early, accurate detection of cancer and organ disease remains limited by cost, reliance on targeted mutation assays, and uncertainty about the signal’s tissue of origin. Many liquid biopsy approaches require... Read more

Immunology

view channel
Image: Mycobacterium tuberculosis bacteria seen with a scanning electron microscope (Credit: CDC PHIL)

Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection

Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more

Pathology

view channel
Image: Spatial characterization of immune–tumor interactions and treatment response across SCLC and extended phenotype models (Cristian Barrera et al, npj Precision Oncology (2026). DOI: 10.1038/s41698-025-01225-9)

AI Pathology Tool Predicts Chemotherapy Response in Small Cell Lung Cancer

Small cell lung cancer often presents at an extensive stage and progresses rapidly, leaving little time to tailor first-line therapy. Clinicians currently lack biomarkers to guide which patients will benefit... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.